$40m and bigger

Celsius Therapeutics, which has launched with series A capital, has become the latest Third Rock-launched company to be backed by GV.

Celsius Therapeutics, a US-based startup developing treatments for cancer and autoimmune diseases, launched yesterday with $65m of series A financing from investors including GV, a subsidiary of internet technology conglomerate Alphabet.

Venture capital firm Third Rock Ventures led the round, which included managed care provider Heritage…Read More.